<DOC>
	<DOCNO>NCT01436838</DOCNO>
	<brief_summary>Non-adherence reduces treatment benefit bias assessment treatment efficacy thereby involve safety risk patient influence health cost-effectiveness . This observational study concentrate upon role MS nurse influence adherence . This study examine influence initial subsequent periodic nurse interview aim improve adherence BetaferonÂ® treatment .</brief_summary>
	<brief_title>China Betaferon Adherence , Coping Nurse Support Study</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Chronic Progressive</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-beta</mesh_term>
	<mesh_term>Interferon beta-1b</mesh_term>
	<criteria>Relapsingremitting multiple scelrosis ( RRMS ) secondary progressive multiple sclerosis ( SPMS ) patient Having Betaferon treatment , include patient First time use ; Restaring ; Switching disease modify drug ( DMDs ) Known newly identify contraindication administration Betaferon accord Summary Product Characteristic ( SmPC ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Relapsing-Remitting Multiple Sclerosis</keyword>
	<keyword>Secondary Progressive Multiple Sclerosis</keyword>
</DOC>